Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 14903

1.

Efficacy of levetiracetam versus fosphenytoin for the recurrence of seizures after status epilepticus.

Nakamura K, Inokuchi R, Daidoji H, Naraba H, Sonoo T, Hashimoto H, Tokunaga K, Hiruma T, Doi K, Morimura N.

Medicine (Baltimore). 2017 Jun;96(25):e7206. doi: 10.1097/MD.0000000000007206.

2.

Medical management and antiepileptic drugs in hypothalamic hamartoma.

Helen Cross J, Spoudeas H.

Epilepsia. 2017 Jun;58 Suppl 2:16-21. doi: 10.1111/epi.13758.

PMID:
28591485
3.

Risks and Benefits of Immediate Antiepileptic Drug Treatment for a First Unprovoked Seizure.

Rahim F.

Am J Nurs. 2017 Jun;117(6):46. doi: 10.1097/01.NAJ.0000520254.65083.7c. Review.

PMID:
28541990
4.

Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome.

Devinsky O, Cross JH, Laux L, Marsh E, Miller I, Nabbout R, Scheffer IE, Thiele EA, Wright S; Cannabidiol in Dravet Syndrome Study Group.

N Engl J Med. 2017 May 25;376(21):2011-2020. doi: 10.1056/NEJMoa1611618.

PMID:
28538134
5.

Nursing a critically ill tetanus patient in an intensive care unit in Zambia.

Carter C, Viveash S.

Br J Nurs. 2017 May 11;26(9):489-496. doi: 10.12968/bjon.2017.26.9.489.

PMID:
28493767
6.

Individualised prediction model of seizure recurrence and long-term outcomes after withdrawal of antiepileptic drugs in seizure-free patients: a systematic review and individual participant data meta-analysis.

Lamberink HJ, Otte WM, Geerts AT, Pavlovic M, Ramos-Lizana J, Marson AG, Overweg J, Sauma L, Specchio LM, Tennison M, Cardoso TMO, Shinnar S, Schmidt D, Geleijns K, Braun KPJ.

Lancet Neurol. 2017 Jul;16(7):523-531. doi: 10.1016/S1474-4422(17)30114-X. Epub 2017 May 5. Review.

PMID:
28483337
7.

Development and pharmacologic characterization of the rat 6 Hz model of partial seizures.

Metcalf CS, West PJ, Thomson KE, Edwards SF, Smith MD, White HS, Wilcox KS.

Epilepsia. 2017 Jun;58(6):1073-1084. doi: 10.1111/epi.13764. Epub 2017 Apr 27.

PMID:
28449218
8.

The epileptology of Koolen-de Vries syndrome: Electro-clinico-radiologic findings in 31 patients.

Myers KA, Mandelstam SA, Ramantani G, Rushing EJ, de Vries BB, Koolen DA, Scheffer IE.

Epilepsia. 2017 Jun;58(6):1085-1094. doi: 10.1111/epi.13746. Epub 2017 Apr 25.

PMID:
28440867
9.

Early discontinuation of antiseizure medications in neonates with hypoxic-ischemic encephalopathy.

Fitzgerald MP, Kessler SK, Abend NS.

Epilepsia. 2017 Jun;58(6):1047-1053. doi: 10.1111/epi.13745. Epub 2017 Apr 12.

PMID:
28401998
10.

The impact of nonadherence to antiseizure drugs on seizure outcomes in an animal model of epilepsy.

Thomson KE, Modi AC, Glauser TA, Rausch JR, Steve White H.

Epilepsia. 2017 Jun;58(6):1054-1062. doi: 10.1111/epi.13742. Epub 2017 Apr 12.

PMID:
28401980
11.

Comparison of levetiracetam and oxcarbazepine monotherapy among Korean patients with newly diagnosed focal epilepsy: A long-term, randomized, open-label trial.

Kim JH, Lee SK, Loesch C, Namgoong K, Lee HW, Hong SB; Korean N01367 Study Group.

Epilepsia. 2017 Apr;58(4):e70-e74. doi: 10.1111/epi.13707.

PMID:
28395124
12.

WONOEP appraisal: Development of epilepsy biomarkers-What we can learn from our patients?

Jozwiak S, Becker A, Cepeda C, Engel J Jr, Gnatkovsky V, Huberfeld G, Kaya M, Kobow K, Simonato M, Loeb JA.

Epilepsia. 2017 Jun;58(6):951-961. doi: 10.1111/epi.13728. Epub 2017 Apr 7. Review.

PMID:
28387933
13.

Alleviation of Oxidative Damage and Involvement of Nrf2-ARE Pathway in Mesodopaminergic System and Hippocampus of Status Epilepticus Rats Pretreated by Intranasal Pentoxifylline.

Kang Y, Yan W, Fang H, Zhang G, Du Y, Wang L, Cui H, Shi G.

Oxid Med Cell Longev. 2017;2017:7908072. doi: 10.1155/2017/7908072. Epub 2017 Mar 12.

14.

Reasons for discontinuation of reversible contraceptive methods by women with epilepsy.

Mandle HB, Cahill KE, Fowler KM, Hauser WA, Davis AR, Herzog AG.

Epilepsia. 2017 May;58(5):907-914. doi: 10.1111/epi.13734. Epub 2017 Apr 3.

PMID:
28369748
15.

Epilepsy: Is there hope?

Guerreiro CA.

Indian J Med Res. 2016 Nov;144(5):657-660. doi: 10.4103/ijmr.IJMR_1051_16. Review.

16.

The impact of seizures on epilepsy outcomes: A national, community-based survey.

Josephson CB, Patten SB, Bulloch A, Williams JVA, Lavorato D, Fiest KM, Secco M, Jette N.

Epilepsia. 2017 May;58(5):764-771. doi: 10.1111/epi.13723. Epub 2017 Mar 27.

PMID:
28345152
17.

Prognostic analysis for short- and long-term outcomes of newly diagnosed epilepsy.

Jiang YL, Yuan F, Yang F, Sun XL, Yang XA, Song L, Jiang W.

Seizure. 2017 Apr;47:92-98. doi: 10.1016/j.seizure.2017.02.018. Epub 2017 Mar 18.

PMID:
28343009
18.

Epileptic activity in Alzheimer's disease: causes and clinical relevance.

Vossel KA, Tartaglia MC, Nygaard HB, Zeman AZ, Miller BL.

Lancet Neurol. 2017 Apr;16(4):311-322. doi: 10.1016/S1474-4422(17)30044-3. Review.

PMID:
28327340
19.

Synthesis and Anticonvulsant Properties of New 3,3-Diphenyl-2,5-dioxo-pyrrolidin-1-yl-acetamides and 3,3-Diphenyl-propionamides.

Obniska J, Rapacz A, Rybka S, Góra M, Żmudzki P, Kamiński K.

Arch Pharm (Weinheim). 2017 Apr;350(3-4). doi: 10.1002/ardp.201600368. Epub 2017 Mar 20.

PMID:
28317156
20.

New developments in the management of partial-onset epilepsy: role of brivaracetam.

Coppola G, Iapadre G, Operto FF, Verrotti A.

Drug Des Devel Ther. 2017 Mar 6;11:643-657. doi: 10.2147/DDDT.S103468. eCollection 2017. Review.

Supplemental Content

Loading ...
Support Center